| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE | 204058 | 003 | ANDA | HYDROCHLOROTHIAZIDE; LISINOPRIL | TABLET;ORAL | 25MG;20MG | No | Yes | 2017/05/23 | 2017/05/23 | INVAGEN PHARMS | Prescription |
| LISINOPRIL | 212041 | 001 | ANDA | LISINOPRIL | TABLET;ORAL | 2.5MG | No | No | 2020/09/15 | 2020/09/15 | SCIEGEN PHARMS INC | Prescription |
| LISINOPRIL | 212041 | 002 | ANDA | LISINOPRIL | TABLET;ORAL | 5MG | No | No | 2020/09/15 | 2020/09/15 | SCIEGEN PHARMS INC | Prescription |
| LISINOPRIL | 212041 | 003 | ANDA | LISINOPRIL | TABLET;ORAL | 10MG | No | No | 2020/09/15 | 2020/09/15 | SCIEGEN PHARMS INC | Prescription |
| LISINOPRIL | 208920 | 001 | ANDA | LISINOPRIL | TABLET;ORAL | 20MG | No | No | 2021/03/04 | 2021/03/04 | SCIEGEN PHARMS INC | Prescription |
| LISINOPRIL | 208920 | 002 | ANDA | LISINOPRIL | TABLET;ORAL | 30MG | No | No | 2021/03/04 | 2021/03/04 | SCIEGEN PHARMS INC | Prescription |
| LISINOPRIL | 208920 | 003 | ANDA | LISINOPRIL | TABLET;ORAL | 40MG | No | No | 2021/03/04 | 2021/03/04 | SCIEGEN PHARMS INC | Prescription |